Skip to content
Market Tracked raises in 2026$3.41B+$183M this week Rounds76 LatestBlue J$176M Series E Tuesday, November 10

Parambil

Parambil is AI medical record review software for mass tort and complex litigation.

SettLiT

SettLiT operates a consent-based health data platform for personal injury and mass tort law firms to retrieve, structure, and review medical, claims, pharmacy, and provider information.

Parambil vs SettLiT

At a Glance

DetailParambilSettLiT
CategoryeDiscoveryeDiscovery
Total raised$8MNot disclosed
Rounds tracked2Not disclosed
Latest roundSeed, $6M · Jan 2026Not disclosed
Last valuationNot disclosedNot disclosed
Lead investorsBling Capital, Daybreak VenturesNot disclosed
Built forMid-size firms, BoutiquesNot disclosed
HeadquartersUnited StatesNot disclosed

Funding, Side by Side

Parambil$8M
SettLiTUndisclosed
Parambil rounds
  1. Jan 2026Seed$6M
  2. Jan 2025Seed$2M
SettLiT rounds

No public rounds tracked yet.

Our Take

We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.

Quick Answers

Which has raised more, Parambil or SettLiT?
Parambil has raised $8M in disclosed funding, compared with no disclosed amount for SettLiT.
What is Parambil best for?
Parambil is AI medical record review software for mass tort and complex litigation.
What is SettLiT best for?
SettLiT operates a consent-based health data platform for personal injury and mass tort law firms to retrieve, structure, and review medical, claims, pharmacy, and provider information.

Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.